{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:05:58Z","timestamp":1790154358965,"version":"4.0.1"},"reference-count":25,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Technol Assess Health Care"],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>From its inception in 1999, the National Institute for Health and Care Excellence (NICE) committed to including the expertise, experiences, and perspectives of lay people, patients and carers, and patient organizations in its health technology assessments (HTAs). This is our story of patient involvement in HTA: from early methods designed for use when assessing medicines, widening to address the different requirements of HTAs for interventional procedures, medical technologies, and diagnostic technologies. We also chart the evolution and development of all our patient involvement methods over the past 20 years through regular evaluation and by responding to external challenge. However, we know that processes and methods alone are not enough. Through case studies we demonstrate the value of patient involvement in HTA and highlight the unique perspectives and experiences that patients bring to HTA committees. Finally, we discuss the underpinning principles and commitments that have made NICE a world leader in delivering meaningful and legitimate patient involvement.<\/jats:p>","DOI":"10.1017\/s0266462320000860","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T08:01:08Z","timestamp":1604995268000},"source":"Crossref","is-referenced-by-count":26,"title":["Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story"],"prefix":"10.1017","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1626-1224","authenticated-orcid":false,"given":"Laura","family":"Norburn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-5919","authenticated-orcid":false,"given":"Lizzie","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"S0266462320000860_ref12","unstructured":"12. National Institute for Health and Care Excellence (NICE) [Internet]. Interventional procedures programme manual, 10.3, c2016 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/process\/pmg28\/chapter\/advice-and-commentary#contributions-from-patient-commentators"},{"key":"S0266462320000860_ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1369-6513.2001.00106.x"},{"key":"S0266462320000860_ref1","unstructured":"1. National Institute for Health and Care Excellence (NICE) [Internet]. History of NICE c2019 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/about\/who-we-are\/history-of-nice"},{"key":"S0266462320000860_ref4","volume-title":"User involvement\u2014a guide to developing effective user involvement strategies in the NHS","author":"Kelson","year":"1997"},{"key":"S0266462320000860_ref15","unstructured":"15. National Institute for Health and Clinical Excellence (NICE) [Internet]. PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites, 3.12, c2012 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/guidance\/mtg9\/chapter\/3-Clinical-evidence"},{"key":"S0266462320000860_ref2","unstructured":"2. National Institute for Health and Care Excellence (NICE) [Internet]. Our principles c2020 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/about\/who-we-are\/our-principles"},{"key":"S0266462320000860_ref9","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-4068-9_34"},{"key":"S0266462320000860_ref13","unstructured":"13. National Institute for Health and Care Excellence (NICE) [Internet]. Medical technologies evaluation programme process guide c2017 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/process\/pmg34\/chapter\/introduction"},{"key":"S0266462320000860_ref16","unstructured":"16. National Institute for Health and Care Excellence (NICE) [Internet]. gammaCore for cluster headache c2019 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/guidance\/mtg46"},{"key":"S0266462320000860_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-4068-9_23"},{"key":"S0266462320000860_ref18","unstructured":"18. Livingstone, H , Thomas, L , Thomas, V , Kastoryano, C , Leng, G [Internet]. Stakeholder Views as Evidence For NICE's Public Involvement Review. In: HTAi Annual Meeting 2018 Vancouver Canada\u2014Strengthening the Evidence-to-Action Connection: Abstract Book, p. 109\u201310 [cited 2020 May 28]; Available from: https:\/\/htai.org\/wp-content\/uploads\/2018\/08\/AM18_Abstract-Book.pdf"},{"key":"S0266462320000860_ref3","unstructured":"3. Health Technology Assessment International (HTAi) [Internet]. Values and standards for patient involvement in HTA c2014 [cited 2020 May 28]; Available from: https:\/\/htai.org\/interest-groups\/pcig\/values-and-standards\/"},{"key":"S0266462320000860_ref11","unstructured":"11. National Institute for Health and Care Excellence (NICE) [Internet]. Vedolizumab for treating moderately to severely active ulcerative colitis c2015 [cited 2020 May 29]; Available from: https:\/\/www.nice.org.uk\/guidance\/ta342\/chapter\/4-Consideration-of-the-evidence"},{"key":"S0266462320000860_ref8","unstructured":"8. National Institute for Health and Care Excellence (NICE) [Internet]. Guide to the processes of technology appraisal c2018 [cited 2020 May 30]; Available from: https:\/\/www.nice.org.uk\/process\/pmg19\/chapter\/introduction"},{"key":"S0266462320000860_ref20","unstructured":"20. Department of Health [Internet]. Report of the Triennial Review of the National Institute for Health and Care Excellence c2015 [cited 2020 May 30]; Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/447317\/NICE_Triennial_Review_Report.pdf"},{"key":"S0266462320000860_ref23","unstructured":"23. Health Technology Assessment International (HTAi) [Internet]. Resources and materials: for patient groups and individual patients c2013 [cited 2020 May 30]; Available from: https:\/\/htai.org\/interest-groups\/pcig\/resources\/for-patients-and-patient-groups\/"},{"key":"S0266462320000860_ref25","unstructured":"25. Livingstone, H , Thomas, V , Leng, G. Methods of patient involvement now and beyond 2020: a case study. In Cologne: HTAi Annual Meeting 2019 Germany\u2014HTA Beyond 2020: Ready for The New Decade? Abstract Book, p. 162 [cited 2020 May 28]; Available from: https:\/\/htai.org\/wp-content\/uploads\/2019\/08\/htai_AM19_abstracts_20190812.pdf"},{"key":"S0266462320000860_ref17","unstructured":"17. National Institute for Health and Care Excellence (NICE) [Internet]. Medical technology consultation: gammaCore for cluster headache\u2014supporting documentation\u2014committee papers, p. 385\u2013402, c2019 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/guidance\/mtg46\/documents\/supporting-documentation"},{"key":"S0266462320000860_ref6","volume-title":"Patient and public involvement policy","year":"2010"},{"key":"S0266462320000860_ref14","unstructured":"14. National Institute for Health and Clinical Excellence (NICE) [Internet]. PleurX peritoneal catheter drainage system assessment report overview appendices, p. 5. c2012 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/guidance\/mtg9\/documents\/pleurx-peritoneal-catheter-drainage-system-assessment-report-overview-appendices2"},{"key":"S0266462320000860_ref24","unstructured":"24. National Institute for Health and Care Excellence (NICE) [Internet]. Improving how patients and the public can help develop NICE guidance and standards c2016 [cited 2020 May 28]; Available from: https:\/\/www.nice.org.uk\/Media\/Default\/About\/NICE-Communities\/Public-involvement\/public-involvement-review-consultation-paper.pdf"},{"key":"S0266462320000860_ref19","unstructured":"19. House of Commons Health Select Committee [Internet]. Eighth Report: National Institute for Health and Clinical Excellence c2013 [cited 2020 May 28]; Available from: https:\/\/publications.parliament.uk\/pa\/cm201213\/cmselect\/cmhealth\/782\/78206.htm#a6"},{"key":"S0266462320000860_ref7","first-page":"29","volume-title":"Patients, the public and priorities in healthcare","author":"Amis","year":"2009"},{"key":"S0266462320000860_ref21","unstructured":"21. Canadian Agency for Drugs and Technologies in Health (CADTH) [Internet]. Instructions for Providing Patient Input to the CADTH Common Drug Review c2019 [cited 2020 May 28]; Available from: https:\/\/www.cadth.ca\/sites\/default\/files\/cdr\/cdr-pdf\/Instructions_for_Providing_Patient_Input_to_CDR.pdf"},{"key":"S0266462320000860_ref22","unstructured":"22. Tonkinson, A , Livingstone, H , Upadhyaya, S , Leng, G [Internet]. Enhancing capability: patient impact In ultra-orphan conditions. In Cologne: HTAi Annual Meeting 2019 Germany\u2014HTA Beyond 2020: Ready For The New Decade? Abstract Book, p. 30\u201331 [cited 2020 May 28]; Available from: https:\/\/htai.org\/wp-content\/uploads\/2019\/08\/htai_AM19_abstracts_20190812.pdf"}],"container-title":["International Journal of Technology Assessment in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0266462320000860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T15:26:52Z","timestamp":1618241212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0266462320000860\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021]]}},"alternative-id":["S0266462320000860"],"URL":"https:\/\/doi.org\/10.1017\/s0266462320000860","relation":{},"ISSN":["0266-4623","1471-6348"],"issn-type":[{"value":"0266-4623","type":"print"},{"value":"1471-6348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"article-number":"e15"}}